Aspirin Current Events | Page 2

Aspirin Current Events, Aspirin News Articles.
Sort By: Most Viewed | Most Recent
Page 2 of 25 | 1000 Results
How our DNA may prevent bowel cancer
A new study published in the prestigious Journal of the American Medical Association suggests the link between aspirin and colon cancer prevention may depend on a person's individual genetics. (2015-03-23)

Long-term, regular aspirin use associated with significant reduction in colorectal cancer risk
Women who took two or more aspirin or NSAIDs per week for more than 10 years significantly reduced their risk of colorectal cancer, according to an article in the August 24/31 issue of JAMA. (2005-08-23)

Aspirin may accelerate progression of advanced cancers in older adults
For older adults with advanced cancer, initiating aspirin may increase their risk of disease progression and early death. (2020-08-10)

Higher daily dose of aspirin could play key role in preventing heart attacks for those with diabetes
A new study by University of Alberta researcher Scot Simpson has shed light on the use of Aspirin as a preventative measure for cardiovascular disease and reoccurrence in patients with diabetes. The study collected data from clinical trials that looked at whether taking aspirin as a course of treatment would prevent a first or recurrent heart attack or stroke. (2011-07-05)

New 'Aspirin-Guide' app for clinicians helps personalize decisions about aspirin use
To help clinicians and patients make informed decisions about aspirin use, researchers at Brigham and Women's Hospital have developed a new, free, mobile app, 'Aspirin-Guide' that calculates both the CVD risk score and the bleeding risk score for the individual patient, and helps clinicians decide which patients are appropriate candidates for the use of low-dose aspirin. (2016-06-20)

Study shows aspirin before a diagnosis may lower colorectal cancer mortality
A new study finds that long-term aspirin use before a diagnosis of colorectal cancer (CRC) may be associated with lower CRC-specific mortality. (2021-02-02)

Genetic variation impacts aspirin's effectiveness in preventing colon cancer, Dartmouth study finds
Dartmouth researchers are among a team of doctors that have learned more about how people may or may not benefit from taking aspirin in the effort to curb colon cancer. (2006-10-24)

Eligibility for aspirin for primary prevention in men increases when cancer mortality benefit added
A research team, including University of North Carolina School of Medicine scientists, reports that including the positive effect of aspirin on cancer mortality influences the threshold for prescribing aspirin for primary prevention in men. (2013-06-06)

Aspirin wins out over its 'super aspirin' challenger
Good old aspirin stood firm against its would-be rival, sibrafiban, in a clot-prevention trial that may spell the end of the oral glycoprotein IIb/IIIa (2000-03-13)

Aspirin steps up as anti-inflammatory for arteries
Americans with heart disease may have yet another reason to use aspirin, according to a report in today's rapid access Circulation: Journal of the American Heart Association. Researchers found that aspirin can protect the blood vessels from dysfunction caused by even mild inflammation. (2002-05-13)

Results of Yale study confirm aspirin helpful in preventing a first heart attack
An overview of four studies examining the use of aspirin and the reduction of heart attacks in persons with no previous history of cardiovascular disease shows aspirin remains a good preventive measure. Individuals that took aspirin had a 32 percent reduction in nonfatal heart attacks. There was, however, a slight increase in the risk of hemorrhagic stroke associated with aspirin use. (2000-11-20)

Aspirin withdrawal may pose risk to coronary patients
Patients with coronary artery disease who stop taking aspirin may be at risk for developing withdrawal-related coronary events, says a new study presented at CHEST 2003, the 69th annual international scientific assembly of the American College of Chest Physicians (ACCP). The study found that previously stable coronary patients experienced coronary events, including unstable angina and myocardial infarction (heart attack), within one week of aspirin withdrawal. (2003-10-29)

An aspirin a day keeps colorectal cancer away
Long term use of 300mg or more of aspirin a day for five years can prevent colorectal cancer, conclude authors of a study published in this week's special gastroenterology edition of the Lancet. (2007-05-10)

An alternative theory on how aspirin may thwart cancer
Many studies have pointed to a role for aspirin in cancer prevention. Scientists have been unsure how the drug works in this regard, although they usually cite aspirin's anti-inflammatory effect. Now, lab studies by Veterans Affairs researchers and colleagues point to a different mechanism. It involves aspirin's action against platelets, the blood cells that play a role in forming clots -- and new blood vessels, which can aid tumor growth. (2017-02-08)

Low doses of aspirin help prevent some strokes; high doses may increase risk for others
When it comes to aspirin as a way to prevent stroke in healthy individuals, less may be more according to a study in the current issue of Stroke: Journal of the American Heart Association. (1999-09-02)

Aspirin reduces the risk of cardiovascular events, though effects differ between men and women
An analysis of previous studies indicates that use of aspirin significantly reduces the risk of cardiovascular events in women and in men, due to reducing the risk of stroke in women and reducing the risk of heart attack in men, according to a study in the January 18 issue of JAMA. (2006-01-17)

Low-dose aspirin reduces cardiovascular events
Taking low-dose aspirin daily reduces the risk of heart attack and stroke, as well as the risk of dying, among patients who previously have had a heart attack or stroke but whose cardiovascular disease has stabilized, according to a new analysis by Duke University Medical Center cardiologists. (2006-11-15)

Aspirin does little or nothing for hard arteries, University of Florida researchers find
For decades, aspirin has been widely used to reduce the risk of cardiovascular problems. Now, a team led by a University of Florida Health researcher has found that aspirin may provide little or no benefit for certain patients who have plaque buildup in their arteries. (2017-06-05)

Cons of regular low-dose aspirin to stave off serious illness in women outweigh pros
The pros of giving healthy women regular low-dose aspirin to stave off serious illness, such as cancer and heart disease, are outweighed by the cons, suggests a large study published online in the journal Heart. (2014-12-04)

Report says new evidence could tip the balance in aspirin cancer prevention care
A new report by American Cancer Society scientists says new data showing aspirin's potential role in reducing the risk of cancer death bring us considerably closer to the time when cancer prevention can be included in clinical guidelines for the use of aspirin in preventative care. (2012-04-09)

Does aspirin lower colorectal cancer risk in older adults? It depends on when they start.
A new study has found that there is no protection against colorectal cancer if people begin taking aspirin regularly after age 70. However, there appears to be such protection if aspirin is started before age 70 and continued. (2021-01-21)

Despite benefits, aspirin greatly underused in people with heart disease
Too few Americans who have heart disease take aspirin to help prevent a recurrent heart attack and other cardiovascular problems, according to a report in today's Circulation: Journal of the American Heart Association. (2000-03-12)

Fighting cancer with aspirin?
When looking for new weapons in the war on cancer, scientists should turn to their medicine cabinets for an age-old remedy -- aspirin. Scientists at the University of Newcastle have determined that aspirin has cancer-fighting effects extending beyond Cox inhibitors. This finding, appearing in the October 2006 issue of the FASEB Journal, allows researchers to pursue new lines of investigation that could ultimately yield a new type of cancer-fighting drug. (2006-10-02)

Terutroban fails to outperform aspirin in secondary stroke prevention trial; aspirin remains gold standard (PERFORM study)
Patients who have had an ischemic stroke or transient ischemic attack (TIA) are at high risk of recurrent stroke or other cardiovascular events. In the PERFORM study, published online first and in an upcoming Lancet, a new drug terutroban was found not to outperform aspirin at preventing a second stroke or TIA. (2011-05-25)

Risks of gastrointestinal ulcers linked to aspirin use might outweigh its benefits for the heart
Doctors should consider whether patients are at high risk of stomach ulcers before prescribing aspirin treatment. A study published today in the open access journal BMC Medicine reveals that low-dose aspirin treatment may be responsible for one extra case of gastrointestinal complications, which include ulcer bleeding or perforation, in every 50 aspirin users per year in susceptible groups, such as older men with a history of peptic ulcer. (2006-09-19)

Researchers find molecular link behind aspirin's protective powers
Researchers at Duke Health have identified a new mechanism of aspirin's action that appears to explain the drug's diverse benefits. (2016-09-07)

Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent
The London School of Hygiene & Tropical Medicine has contributed to a study showing that a low dose of aspirin reduces the occurrence of several common cancers. The study is published in today's Lancet. (2010-12-06)

Lab study: Daily aspirin could block growth of breast, other cancers
A Veterans Affairs lab study found that a daily dose of aspirin was effective at blocking breast tumor growth. Previous studies have already shown a similar effect on colon, gastrointestinal, prostate, and other cancers. (2015-06-11)

Yale study shows aspirin as effective as anti-clotting drug in reducing post-heart attack risk
Heart attack sufferers can benefit as much from taking one aspirin a day after their trauma as from taking aspirin along with a powerful anti-clotting drug, a Yale study shows. The study, one of the largest of its kind, appears to settle the controversy over the best long-term treatment for heart attack sufferers -- aspirin or the anti-clotting drug, Coumadin. (1999-11-09)

Aspirin therapy may not help patients with peripheral vascular disease, researchers find
Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis by University of Florida Health researchers has found. (2017-04-12)

Aspirin does not reduce effectiveness of ACE inhibitors
A systematic review in this week's issue of The Lancet provides clarification for the debate about the use of angiotensin-converting-enzyme (ACE) inhibitors in combination with aspirin for the treatment of cardiovascular disease-combination therapy does not reduce the effect of ACE inhibition. (2002-10-03)

Aspirin use may be associated with increased risk of pancreatic cancer
Regular aspirin use for 20 years or more may be associated with an increased risk of pancreatic cancer in women, the fourth leading cause of cancer-related deaths in the United States, according to a study in the January 7 issue of the Journal of the National Cancer Institute. (2004-01-06)

A new form of aspirin to overcome 'aspirin resistance'
Scientists are reporting development of a new form of aspirin -- taken daily by about 60 million people in the United States alone to reduce the risk of heart attack and stroke -- that could extend aspirin's benefits to people who may not respond to the drug. Their advance toward coping with (2013-09-04)

Aspirin's health benefits under scrutiny
Taking a baby aspirin every day to prevent a heart attack or stroke should no longer be recommended to patients who haven't already experienced one of these events. (2019-12-09)

Canadians told to stop taking aspirin to prevent first heart attack, stroke
If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research. Researchers at the University of Alberta Kolber reviewed three large, randomized, placebo-controlled studies published in 2018 that showed the risk of major internal bleeding associated with taking an aspirin a day is higher than any preventative benefits. (2019-10-02)

Daily aspirin usage associated with lower cancer mortality
Daily aspirin usage is associated with lower overall cancer mortality, but the association may be smaller than what was previously believed, according to a study published Aug. 10 in the Journal of the National Cancer Institute. (2012-08-10)

Aspirin can prevent liver damage that afflicts millions, Yale study finds
Simple aspirin may prevent liver damage in millions of people suffering from side effects of common drugs, alcohol abuse and obesity-related liver disease, a new Yale University study suggests. (2009-01-26)

Over-the-counter pain medications may reduce risk of Parkinson's disease
Over-the-counter pain medications known as non-steroidal anti-inflammatory drugs may reduce a person's risk of Parkinson's disease, according to a study published in the Nov. 6, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. (2007-11-05)

Aspirin reduces long-term colorectal cancer risk in genetically predisposed individuals
Aspirin reduces colorectal cancer risk by half in individuals at high genetic risk. Preventive efficacy is prolonged for 10-20 years after treatment with aspirin. (2020-06-11)

Postmenopausal women with heart disease should take aspirin
Aspirin can significantly reduce death rates for postmenopausal women with heart disease, according to a new analysis by Duke University Medical Center cardiologists (2005-11-15)

Page 2 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to